Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-18

Clinical Trial Update: The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial investigates how glucose-dependent insulinotropic peptide (GIP) influences postprandial splanchnic blood flow distribution and metabo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Copenhagen | Conditions: Blood Flow | NA | Status: COMPLETED